Cigna and Express Scripts have received approval from the last state necessary to complete their $67 billion merger, setting the stage for the deal to close on Thursday.
In a financial filing, Cigna said it received final approval from New Jersey regulators on Tuesday.
"All required regulatory approvals now have been received and the parties expect to close the transaction on December 20, 2018, subject to the satisfaction of all other closing conditions," the company stated.
RELATED: With merger vote approaching, Cigna and Express Scripts diverge on value-based contracts
Cigna and Express Scripts secured approvals from New York and California last week with promises to invest $60 million into California's healthcare system and assurances that it would not raise premiums to pay for the costs of the deal.
The companies won approval from the Department of Justice in September.
With the deal poised to close, the combination of Cigna and Express Scripts marks the second vertical megamerger to finalize this year. CVS closed it's $69 billion acquisition of Aetna earlier this month, although the companies are still ironing out approval from a D.C. district court judge.